Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma.
The use of superactive LHRH analogue to provide a reversible form of castration is discussed in the context of the management of a patient with benign metastasizing leiomyoma. The aetiology and prognosis of this rare disease are briefly considered.
D000328:Adult; D002064:Buserelin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary*; D010052:Ovariectomy; D010053:Ovary / Q000473:pathology; D014594:Uterine Neoplasms / Q000473:pathology
D002064:Buserelin